Potential role of mesenchymal stromal cells in pancreatic islet transplantation

Peiman Hematti, Jaehyup Kim, Andrew P. Stein, Dixon Kaufman

Research output: Contribution to journalReview article

39 Citations (Scopus)

Abstract

Pancreatic islet transplantation is an attractive option for treatment of type 1 diabetes mellitus but maintaining long term islet function remains challenging. Mesenchymal stromal cells (MSCs), derived from bone marrow or other sources, are being extensively investigated in the clinical setting for their immunomodulatory and tissue regenerative properties. Indeed, MSCs have been already tested in some feasibility studies in the context of islet transplantation. MSCs could be utilized to improve engraftment of pancreatic islets by suppressing inflammatory damage and immune mediated rejection. In addition to their immunomodulatory effects, MSCs are known to provide a supportive microenvironmental niche by secreting paracrine factors and depositing extracellular matrix. These properties could be used for in vivo co-transplantation to improve islet engraftment, or for in vitro co-culture to prime freshly isolated islets prior to implantation. Further, tissue specific pancreatic islet derived MSCs may open new opportunities for its use in islet transplantation as those cells might be more physiological to pancreatic islets.

Original languageEnglish (US)
Pages (from-to)21-29
Number of pages9
JournalTransplantation Reviews
Volume27
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Islets of Langerhans Transplantation
Mesenchymal Stromal Cells
Islets of Langerhans
Feasibility Studies
Coculture Techniques
Type 1 Diabetes Mellitus
Extracellular Matrix
Transplantation
Bone Marrow

ASJC Scopus subject areas

  • Transplantation

Cite this

Potential role of mesenchymal stromal cells in pancreatic islet transplantation. / Hematti, Peiman; Kim, Jaehyup; Stein, Andrew P.; Kaufman, Dixon.

In: Transplantation Reviews, Vol. 27, No. 1, 01.01.2013, p. 21-29.

Research output: Contribution to journalReview article

Hematti, Peiman ; Kim, Jaehyup ; Stein, Andrew P. ; Kaufman, Dixon. / Potential role of mesenchymal stromal cells in pancreatic islet transplantation. In: Transplantation Reviews. 2013 ; Vol. 27, No. 1. pp. 21-29.
@article{bb8564ab7fcd4813a3f7942c19fb8a00,
title = "Potential role of mesenchymal stromal cells in pancreatic islet transplantation",
abstract = "Pancreatic islet transplantation is an attractive option for treatment of type 1 diabetes mellitus but maintaining long term islet function remains challenging. Mesenchymal stromal cells (MSCs), derived from bone marrow or other sources, are being extensively investigated in the clinical setting for their immunomodulatory and tissue regenerative properties. Indeed, MSCs have been already tested in some feasibility studies in the context of islet transplantation. MSCs could be utilized to improve engraftment of pancreatic islets by suppressing inflammatory damage and immune mediated rejection. In addition to their immunomodulatory effects, MSCs are known to provide a supportive microenvironmental niche by secreting paracrine factors and depositing extracellular matrix. These properties could be used for in vivo co-transplantation to improve islet engraftment, or for in vitro co-culture to prime freshly isolated islets prior to implantation. Further, tissue specific pancreatic islet derived MSCs may open new opportunities for its use in islet transplantation as those cells might be more physiological to pancreatic islets.",
author = "Peiman Hematti and Jaehyup Kim and Stein, {Andrew P.} and Dixon Kaufman",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.trre.2012.11.003",
language = "English (US)",
volume = "27",
pages = "21--29",
journal = "Transplantation Reviews",
issn = "0955-470X",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Potential role of mesenchymal stromal cells in pancreatic islet transplantation

AU - Hematti, Peiman

AU - Kim, Jaehyup

AU - Stein, Andrew P.

AU - Kaufman, Dixon

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Pancreatic islet transplantation is an attractive option for treatment of type 1 diabetes mellitus but maintaining long term islet function remains challenging. Mesenchymal stromal cells (MSCs), derived from bone marrow or other sources, are being extensively investigated in the clinical setting for their immunomodulatory and tissue regenerative properties. Indeed, MSCs have been already tested in some feasibility studies in the context of islet transplantation. MSCs could be utilized to improve engraftment of pancreatic islets by suppressing inflammatory damage and immune mediated rejection. In addition to their immunomodulatory effects, MSCs are known to provide a supportive microenvironmental niche by secreting paracrine factors and depositing extracellular matrix. These properties could be used for in vivo co-transplantation to improve islet engraftment, or for in vitro co-culture to prime freshly isolated islets prior to implantation. Further, tissue specific pancreatic islet derived MSCs may open new opportunities for its use in islet transplantation as those cells might be more physiological to pancreatic islets.

AB - Pancreatic islet transplantation is an attractive option for treatment of type 1 diabetes mellitus but maintaining long term islet function remains challenging. Mesenchymal stromal cells (MSCs), derived from bone marrow or other sources, are being extensively investigated in the clinical setting for their immunomodulatory and tissue regenerative properties. Indeed, MSCs have been already tested in some feasibility studies in the context of islet transplantation. MSCs could be utilized to improve engraftment of pancreatic islets by suppressing inflammatory damage and immune mediated rejection. In addition to their immunomodulatory effects, MSCs are known to provide a supportive microenvironmental niche by secreting paracrine factors and depositing extracellular matrix. These properties could be used for in vivo co-transplantation to improve islet engraftment, or for in vitro co-culture to prime freshly isolated islets prior to implantation. Further, tissue specific pancreatic islet derived MSCs may open new opportunities for its use in islet transplantation as those cells might be more physiological to pancreatic islets.

UR - http://www.scopus.com/inward/record.url?scp=84873570068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873570068&partnerID=8YFLogxK

U2 - 10.1016/j.trre.2012.11.003

DO - 10.1016/j.trre.2012.11.003

M3 - Review article

C2 - 23290684

AN - SCOPUS:84873570068

VL - 27

SP - 21

EP - 29

JO - Transplantation Reviews

JF - Transplantation Reviews

SN - 0955-470X

IS - 1

ER -